| Literature DB >> 33868365 |
Jairus C Pulczinski1, Yan Shang1, Tyna Dao1, Nathachit Limjunyawong1, Qinying Sun1, Wayne Mitzner1, Robert Ys Cheng2, Wan-Yee Tang1,3.
Abstract
Environmental exposures have been linked to increased asthma risk, particularly during pregnancy and in early life. Here we use a mouse model of allergic lung disease to examine the effects of pre- and perinatal house dust mite (HDM) allergen exposure on offspring phenotypic and transcriptional outcomes in three generations. We show that maternal HDM exposure (F0) acts synergistically with adult HDM exposure, leading to enhanced airway hyperresponsiveness (AHR) and lung inflammation when compared to mice exposed solely in adulthood. Additionally, a subset of F1 males were not challenged in adulthood, and used to generate F2 progeny, which was then used to generate F3 progeny. Upon adult challenge to HDM, F2, and F3 males generated from the maternal HDM (F0) exposure lineage displayed increased airway reactivity and inflammation when compared to mice exposed solely in adulthood. These findings indicate that maternal allergen exposure is capable of enhancing either susceptibly to or severity of allergic airway disease. To examine the role of epigenetic inheritance of asthma susceptibility induced by maternal HDM exposure, we utilized a genome-wide MeDIP-seq and hMeDIP-seq analysis to identify genes differentially methylated (DMG) and hydroxymethylated (DHG), and their association with the enhanced AHR. In addition, we validated the relationship between DNA methylation and mRNA expression of the DMGs and DHGs in the male sub-generations (F1-F3). We found the expression of Kchn1, Nron, and Spag17 to be differentially hydroxymethylated and upregulated in the F1 exposed to HDM both in early life and in adulthood when compared to F1 mice exposed solely in adulthood. Kcnh1 remained upregulated in the F2 and F3 from the maternal HDM (F0) exposure lineage, when compared to F1 mice exposed solely in adulthood. In summary, we demonstrated that maternal HDM exposure in early life can alter the gene expression and phenotype of offspring upon adult HDM exposure, resulting in more severe disease. These effects persist at least two generations past the initial insult, transmitted along the paternal line.Entities:
Keywords: DNA hydroxymethylation; DNA methylation; allergen; asthma; epigenetic inheritance
Year: 2021 PMID: 33868365 PMCID: PMC8047068 DOI: 10.3389/fgene.2021.624561
Source DB: PubMed Journal: Front Genet ISSN: 1664-8021 Impact factor: 4.599
FIGURE 1Animal breeding scheme for generation of F1, F2, and F3 progenies. Nulliparous C57BL/6J female mice (F0) were sensitized to house dust mite (indicated by red box) at 8 weeks of age, and then paired with naïve C57BL/6J male mice to generate the F1 progeny. F1 males were paired with naïve C57BL/6J female mice to generate F2 progeny. F2 males were paired with naïve C57BL/6J female mice to generate F3 progeny. A subset of 6 week-males from each generation (F1, F2, and F3) were selected for adult HDM challenge followed by airway hyperresponsiveness (AHR) measurements, and gene expression analysis. Figure created with BioRender.com.
Sequence of primers for qPCR.
| Acox2 | TCCAGAAGGCTTGCACCATT | TTTGCCTCTGGGTCACTAGG |
| Aida | CGCCGACTTCGACTCTTGG | TTTGCCTATGGTTTTCTTTTGTTCT |
| Asmt | CGCCATCTACAGGTCGGAG | GGTCGCAGATGACCCTGAAG |
| Camk2d | TaqMan Probe # mm0049926 | |
| Ccnd1 | ACCTGGGCAGCCCCAACAAC | GGAGGCAGTCCGGGTCACACT |
| Col1a | TTGGGTCCCTCGACTCCTAC | TGACTGTCCCACGTAAGCAC |
| Col23a | ACGGGAGAAGTTGGATGGAG | ATCTCGTCCTGATTGCCCTG |
| Col3a | GAGGGCCATAGCTGAACTGA | TGCAGAGTTAACAACAGTCAGC |
| Dpcd | CGAGCTCATCAAAGAAACCCA | CATCCTTCGGGTAGGGGAGA |
| Dpy19l1 | GCCAGCTGGTACCGGATTTA | CCCAATCCCTCACAGCTCTC |
| Eef2 | GTGGGGAGACCGGTACTTTG | AGAAGGTGCGGGGAAGTTTT |
| Erdr1 | TTAGCCGCAGCTATGGTTTCT | TTCCATTCACGCCCACAGAG |
| Foxi1 | ATGAGGACGACCCAGGCAAAG | TTCCTGCGAAAGTTTCCGTTG |
| Kcnh1 | CTGACCCCAAACTTATCCGCA | CTGATGCCCTCATCCACGTTC |
| Kdm6a | AAACGCACCCACTCTACCTC | CCTTTGTGAAGCCCCTGAGT |
| Lars2 | GGGTTTGGACCCAGAAAAGGA | GAAGACCCTTCTCTGTAAGCTGTG |
| Luzp2 | TCAGCACCAGACAGGACTAT | TCTCTGGATGTCTTTGTCAGC |
| Mlck | TaqMan Probe # mm00653039 | |
| Mrs | ACGGCAAAAGTCTCTCTGAGTT | TCAAAGACATGTGGGTCGCT |
| Muc19 | TTGATGACCCAAGCAACCCA | TTGCTTTGGGCAGTCCTGAA |
| Muc5b | GAAACTGGAGCTGGGCTCTG | ATGGAGTCACTATACACTCTCTGA |
| Nox3 | ACGGAGGAGGTCGCATCATT | GCCTGCCATTCAGCATAGTG |
| Nron | CACGGGTGCTGGATGACATA | ATTTAAGGGAGAGCTGGCGG |
| Oasl2 | GAGACCGGCCCATCATCCT | CTACAGTCGTGCAACAGACCT |
| Pcna | CTGGGACGTCAGCTCGGGCG | TTGGACATGCTGGTGAGGTTCACG |
| Ranbp31 | GTAGGCAGGAGGTGCGATAC | ACTCCTCGAAAAGCATGCCA |
| Rpl19 | GGTGACCTGGATGAGAAGGA | TTCAGCTTGTGGATGTGCTC |
| Sma | CTTCTCCAGGGAGGAAGAGG | ACTACTGCCGAGCGTGAGAT |
| Smpd13a | AGCTGTGGGGCAGTTTTGG | CACACACCTTGGTACGGTCA |
| Spag17 | CACCAACTGCGAGGACAGTA | GTAGCACCTGGTATGACCCC |
| Tmem125 | CCTGTGTGAGAGGTGAGGGTA | TGTCAGGGTTCAGAGGGTGT |
| Ugt8a | TACAGGCAAAAGGCATGGGG | CCTCTGCCGATAACTGGGAT |
| Xcr1 | GAGTCAGATGCTCTCAGTATCCCT | GGACAATGGTAGAGATGGTGGAA |
FIGURE 2Effect of maternal exposure to HDM on sub-generation. (A) Experimental protocol for acute HDM exposure-induced AHR in a mouse model. Nulliparous C57BL/6J female mice (F0), 8-week old, were sensitized with 100 μg HDM or saline (as control) intraperitoneally (i.p.) 2 weeks before conception. Subsequently, these mice were mated with naive C57BL/6J males and then challenged with 100 μg HDM or saline intratracheally (i.t.) three times a week throughout gestation and lactation (total of 6 weeks). F1 offspring were sex separated at weaning. A subset of F1 males were unexposed and mated to naïve, nulliparous C57BL/6J female mice to produce F2 progeny, additionally, a subset of F2 males were left unexposed and mated to naïve, nulliparous C57BL/6J female mice used to produce F3 progeny. Additionally, a subset of F1, F2, and F3 males were subject to acute HDM exposures to examine multigenerational effects of HDM in mice. At 6 weeks, these offspring were sensitized with 100 μg HDM or saline (as control) intraperitoneally (i.p.) on Day (d)0. On d14, mice were challenged with 100 μg HDM or saline intratracheally (i.t.) 3× a week (d14, d18, and d21). On d 23, after airway responsiveness in response to methacholine (Mch) was assessed, lung tissue, blood serum, and bronchoalveolar lavage (BAL) fluid were collected. (B) Mice were administered methacholine (Mch), a bronchoconstrictive agent, at increasing doses (0.1, 0.3, 1, 3, 10, and 30 mg/ml) by a 10-second aerosol inhalation. Resistance at 30 mg/ml of Mch is shown. HDM-challenged mice exhibited increased AHR compared to those exposed to PBS. This was further enhanced by maternal HDM exposure. (C) Total cell count was performed after staining of BAL cells with Turks solution. HDM-challenged mice exhibited increased BAL cell number compared to those exposed to saline. This was further enhanced by maternal HDM exposure. Mean with SEM shown. P values derived from Ordinary One-Way ANOVA with Tukey’s test for multiple comparisons. *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001.
mRNA levels of AHR phenotypic genes in F1 progenies.
| Ccnd1 | 1.838 | 0.708 | 26.169 | 4.708 | 1.339 | 0.206 | 0.899 | 28.630 | 4.786 | 0.072 | 0.981 | |
| Pcna | 0.353 | 0.040 | 4.483 | 0.949 | 0.065 | 1.896 | 0.592 | 0.279 | 5.225 | 0.509 | 0.897 | |
| Col1a | 0.285 | 0.092 | 0.486 | 0.121 | 0.587 | 0.346 | 0.036 | 0.919 | 0.666 | 0.027 | 0.545 | |
| Col3a | 0.638 | 0.178 | 1.087 | 0.127 | 0.310 | 1.071 | 0.251 | 0.563 | 2.003 | 0.187 | 0.136 | 0.056 |
| Muc5b | 1.168 | 0.118 | 1.053 | 0.108 | 0.885 | 1.156 | 0.120 | 1.000 | 1.276 | 0.175 | 0.937 | 0.719 |
| Sma | 0.347 | 0.043 | 0.443 | 0.103 | 0.824 | 0.422 | 0.166 | 0.967 | 0.806 | 0.114 | 0.363 | 0.212 |
| Camk2d | 3.537 | 0.309 | 7.137 | 0.544 | 3.387 | 0.137 | 0.966 | 8.666 | 0.979 | 0.077 | 0.587 | |
| Mylk | 1.146 | 0.187 | 1.230 | 0.043 | 0.967 | 0.989 | 0.160 | 0.914 | 1.164 | 0.094 | 0.787 | 0.913 |
List of differential hydroxymethylated and methylated genes associated with maternal HDM exposures and increased AHR.
| Acox2 | Acyl-Coenzyme A oxidase 2, branched chain | Signaling receptor binding and oxidoreductase activity, acting on the CH-CH group of donors | 14 |
| Aida | Axin interactor, dorsalization associated | protein domain specific binding | 1 |
| Asmt | Acetylserotonin O-methyltransferase | Protein homodimerization activity and methyltransferase activity | X |
| Cdr1 | Cerebellar degeneration related antigen 1 | Protein binding | X |
| Col23a1 | Collagen, type XXIII, alpha 1 | Extracellular matrix structural constituent, protein binding | 11 |
| Dpcd | Deleted in primary ciliary dyskinesia | Protein binding | 19 |
| Dpy19l1 | dpy-19-like 1 | Transferase activity, transferring glycosyl groups and mannosyltransferase activity | 9 |
| Eef2 | Eukaryotic translation elongation factor 2 | Protein kinase binding | 10 |
| Erdr1 | Erythroid differentiation regulator 1 | Not available | Y |
| Foxi1 | Forkhead box I1 | DNA-binding transcription factor activity, RNA polymerase II proximal promoter sequence-specific DNA binding | 11 |
| Kcnh1 | Potassium voltage-gated channel, subfamily H (eag-related), member 1 | Signal transducer activity and ion channel activity | 1 |
| Kdm6a | Lysine (K)-specific demethylase 6A | Protein binding and dioxygenase activity | X |
| Lars2 | Leucyl-tRNA synthetase, mitochondrial | Binding and aminoacyl-tRNA editing activity | 9 |
| Luzp2 | Leucine zipper protein 2 | Extracellular region | 7 |
| Mrs2 | MRS2 magnesium transporter | Magnesium ion transmembrane transporter activity | 13 |
| Muc19 | Mucin 19 | Extracellular region, Golgi lumen, plasma membrane | 15 |
| Nox3 | NADPH oxidase 3 | Oxidoreductase activity and superoxide-generating NADPH oxidase activity | 17 |
| Nron | Non-protein coding RNA, repressor of NFAT | Not available | 2 |
| Oasl2 | 2′-5′ oligoadenylate synthetase-like 2 | RNA binding and transferase activity | 5 |
| Ranbp3l | RAN binding protein 3-like | Contributes to GTPase activator activity, Ran GTPase binding, SMAD binding | 15 |
| Rnu6 | U6 small nuclear RNA | Not available | 17 |
| Smpdl3a | Sphingomyelin phosphodiesterase, acid-like 3A | Hydrolase activity and sphingomyelin phosphodiesterase activity | 10 |
| Spag17 | Sperm associated antigen 17 | Extracellular region, cytoplasm, cytoskeleton, microtubule, cilium | 3 |
| Tmem125 | Transmembrane protein 125 | Membrane, integral component of membrane | 4 |
| Ugt8a | UDP galactosyltransferase 8A | Carbohydrate binding and glucuronosyltransferase activity | 3 |
| Xcr1 | Chemokine (C motif) receptor 1 | G protein-coupled receptor activity and chemokine receptor activity | 9 |
mRNA levels of differential hydroxymethylated and methylated genes in F1 progenies. mRNA levels measured via RTPCR.
| Dpy19l1 | 1.125 | 0.387 | 57.229 | 8.803 | 1.205 | 0.339 | >0.9999 | 41.083 | 8.178 | 0.299 | ||
| Erdr1 | 1.235 | 0.282 | 57.112 | 4.660 | 0.282 | 0.054 | 1.000 | 15.180 | 2.583 | 0.432 | ||
| Kcnh1 | 0.938 | 0.087 | 263.672 | 24.479 | 4.918 | 1.222 | 0.978 | 501.429 | 7.045 | |||
| Lars2 | 0.175 | 0.043 | 32.978 | 7.785 | 0.435 | 0.033 | >0.9999 | 34.603 | 7.404 | 0.998 | ||
| Nron | 0.455 | 0.388 | 24.942 | 3.301 | 0.297 | 0.143 | >0.9999 | 48.291 | 3.409 | 0.058 | ||
| Oasl2 | 0.461 | 0.052 | 33.065 | 3.284 | 0.459 | 0.015 | >0.9999 | 50.182 | 3.798 | 0.249 | ||
| Spag17 | 0.633 | 0.007 | 182.749 | 27.169 | 2.478 | 0.345 | 0.998 | 323.945 | 42.425 | |||
mRNA levels of epigenetic modification enzymes in F1 progenies. mRNA levels measured via RTPCR.
| Dnmt1 | 1.518 | 0.595 | 0.013 | 0.000 | 0.445 | 0.117 | 0.073 | 0.004 | 0.002 | 0.736 | >0.9999 | |
| Dnmt3a | 3.671 | 0.503 | 0.182 | 0.023 | 0.234 | 0.061 | 0.002 | 0.001 | 0.949 | 0.970 | ||
| Dnmt3b | 2.975 | 0.381 | 0.108 | 0.032 | 2.019 | 0.389 | 0.131 | 0.014 | 0.005 | 0.996 | ||
| Mecp2 | 2.412 | 0.248 | 0.906 | 0.163 | 1.518 | 0.066 | 0.174 | 0.119 | 0.003 | 0.219 | ||
| Tet1 | 0.668 | 0.029 | 3.910 | 0.647 | 0.825 | 0.165 | 0.983 | 4.450 | 0.184 | 0.542 | ||
| Tet2 | 1.233 | 0.358 | 1.504 | 0.341 | 0.907 | 1.165 | 0.262 | 0.999 | 1.081 | 0.361 | 0.997 | 0.720 |
FIGURE 3F0 HDM exposure enhances severity to HDM induced airway hyperresponsiveness and cell count in BAL in F2 and F3. (A) F2 Resistance at 30 mg/ml of Mch is shown. F2 progeny from HDM-challenged mice exhibited increased AHR compared to those exposed to PBS. This was further enhanced by maternal HDM exposure. (B) F3 Resistance at 30 mg/ml of Mch is shown. F3 progeny from HDM-challenged mice exhibited increased AHR compared to those exposed to PBS. This was further enhanced by maternal HDM exposure. (C) F2 progeny from HDM-challenged mice exhibited increased BAL cell number compared to those exposed to saline. This was further enhanced by maternal HDM exposure. (D) F2 progeny from HDM-challenged mice exhibited increased BAL cell number compared to those exposed to PBS. This was further enhanced by maternal HDM exposure. Mean with SEM shown. P values derived from Ordinary One-Way ANOVA with multiple comparisons. *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001.
mRNA levels of AHR phenotypic genes in F2 and F3 progenies. mRNA levels measured via RTPCR.
| Ccnd1 | 1.679 | 0.509 | 14.755 | 2.471 | 0.076 | 1.069 | 0.118 | 0.692 | 17.372 | 5.062 | 0.200 | 0.962 |
| Pcna | 0.219 | 0.013 | 4.630 | 1.245 | 0.171 | 0.485 | 0.234 | 0.710 | 3.132 | 0.212 | 0.686 | |
| Col1a | 0.749 | 0.121 | 1.336 | 0.204 | 0.230 | 0.138 | 0.008 | 0.090 | 1.427 | 0.080 | 0.972 | |
| Col3a | 0.416 | 0.120 | 1.478 | 0.114 | 0.676 | 0.092 | 0.427 | 3.143 | 0.163 | |||
| Muc5b | 1.304 | 0.322 | 1.030 | 0.055 | 0.836 | 1.330 | 0.117 | 1.000 | 1.247 | 0.345 | 0.995 | 0.917 |
| Sma | 1.031 | 0.328 | 1.486 | 0.323 | 0.765 | 1.175 | 0.182 | 0.978 | 1.645 | 0.169 | 0.357 | 0.968 |
| Camk2d | 3.424 | 0.059 | 5.152 | 0.421 | 0.128 | 2.208 | 0.091 | 5.381 | 0.737 | 0.118 | 0.992 | |
| Mylk | 1.332 | 0.081 | 1.343 | 0.051 | 1.000 | 0.974 | 0.130 | 0.253 | 1.074 | 0.149 | 0.953 | 0.472 |
| Ccnd1 | 5.201 | 0.937 | 32.478 | 7.568 | 0.072 | 3.886 | 0.880 | 0.742 | 29.012 | 3.948 | 0.975 | |
| Pcna | 0.682 | 0.231 | 4.419 | 0.338 | 0.871 | 0.135 | 0.892 | 4.092 | 0.646 | 0.967 | ||
| Col1a | 1.958 | 0.305 | 3.952 | 0.909 | 0.278 | 3.254 | 0.183 | 3.303 | 0.561 | 1.000 | 0.926 | |
| Col3a | 0.383 | 0.103 | 1.630 | 0.229 | 0.367 | 0.082 | 0.999 | 1.948 | 0.085 | 0.599 | ||
| Muc5b | 2.788 | 0.307 | 4.797 | 0.825 | 0.220 | 3.079 | 0.422 | 0.941 | 4.572 | 0.692 | 0.356 | 0.997 |
| Sma | 1.116 | 0.165 | 2.130 | 0.333 | 0.121 | 0.974 | 0.134 | 0.907 | 1.905 | 0.265 | 0.099 | 0.949 |
| Camk2d | 3.379 | 0.592 | 6.465 | 0.792 | 0.061 | 2.232 | 0.140 | 0.349 | 3.979 | 0.417 | 0.061 | 0.114 |
| Mylk | 1.410 | 0.091 | 3.461 | 0.586 | 0.078 | 1.509 | 0.080 | 0.844 | 2.934 | 0.308 | 0.855 | |
mRNA levels of differential hydroxymethylated and methylated genes in F2 and F3 progenies.
| Kcnh1 | 3.516 | 0.833 | 257.744 | 49.664 | 3.588 | 0.133 | >0.9999 | 374.755 | 112.999 | |||
| Spag17 | 1.533 | 0.202 | 170.063 | 42.397 | 1.457 | 0.317 | >0.9999 | 121.977 | 3.923 | 0.058 | ||
| Kcnh1 | 5.106 | 0.661 | 366.325 | 51.904 | 2.137 | 0.598 | 0.997 | 471.418 | 77.886 | |||
| Spag17 | 3.589 | 0.370 | 138.982 | 32.860 | 1.844 | 0.182 | 0.999 | 160.806 | 26.801 | 0.464 | ||